That's absurd. Any "big" pharmaceutical company that was interested could have had this company out of bankruptcy for a fraction of the 50 cents per share or market cap of over $800M. A mere bid of $15M and everybody, including Auctus, would have left the table happy, as their debts would have been paid off. Shareholders notsomuch, as all the proceeds would have gone to the debt holders.